Gastric Antisecretory Drugs Induce Leukocyte-Endothelial Cell Interactions through Gastrin Release and Activation of CCK-2 Receptors

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Journal of Pharmacology and Experimental Therapeutics

• Publication date

  2007-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1124/jpet.107.122754PMID 17652263
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Changing Patterns

  2019cited by this paper
• Inflammation, atrophy, and gastric cancer.

  2007influential reference
• The histamine H(4) receptor: a novel modulator of inflammatory and immune disorders.

  2007cited by this paper
• Pharmacokinetics of omeprazole after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.

  2007cited by this paper
• Histamine receptors are hot in immunopharmacology.

  2006cited by this paper
• Molecular mechanisms involved in anti-inflammatory effects of proton pump inhibitors

  2006cited by this paper
• Gastrin induces leukocyte‐endothelial cell interactions in vivo and contributes to the inflammation caused by Helicobacter pylori

  2006cited by this paper
• Gastrin enhances the angiogenic potential of endothelial cells via modulation of heparin-binding epidermal-like growth factor.

  2006cited by this paper
• Gastrin — active participant or bystander in gastric carcinogenesis?

  2006cited by this paper
• Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.

  2005influential reference
• Pharmacokinetic changes of oltipraz after intravenous and oral administration to rats with liver cirrhosis induced by dimethylnitrosamine.

  2004cited by this paper
• Gastrin: old hormone, new functions

  2004cited by this paper
• Characterization of Gastrin-Induced Proangiogenic Effects In vivo in Orthotopic U373 Experimental Human Glioblastomas and In vitro in Human Umbilical Vein Endothelial Cells

  2004cited by this paper
• Helicobacter pylori persistence: biology and disease.

  2004cited by this paper
• Regulation of Leukocyte Transmigration: Cell Surface Interactions and Signaling Events 1

  2004cited by this paper
• Treatment of Helicobacter gastritis with IL-4 requires somatostatin

  2003cited by this paper
• Genetic or chemical hypochlorhydria is associated with inflammation that modulates parietal and G-cell populations in mice.

  2002cited by this paper
• Estrogens Inhibit Angiotensin II–Induced Leukocyte–Endothelial Cell Interactions In Vivo via Rapid Endothelial Nitric Oxide Synthase and Cyclooxygenase Activation

  2002cited by this paper
• Identification of CCK-B/gastrin receptor splice variants in human peripheral blood mononuclear cells.

  2001cited by this paper
• Changing Patterns of Helicobacter pylori Gastritis in Long‐Standing Acid Suppression

  2000cited by this paper
• Effect of Helicobacter pylorieradication on chronic gastritis during omeprazole therapy

  2000cited by this paper
• A new mechanism for anti‐inflammatory actions of proton pump inhibitors – inhibitory effects on neutrophil–endothelial cell interactions

  2000cited by this paper
• Mechanisms of gastroprotection by transdermal nitroglycerin in the rat

  1999cited by this paper
• Changes in Helicobacter pylori‐induced gastritis in the antrum and corpus during 12 months of treatment with omeprazole and lansoprazole in patients with gastro‐oesophageal reflux disease

  1998cited by this paper
• Changes in Helicobacter pylori‐induced gastritis in the antrum and corpus during and after 12 months of treatment with ranitidine and lansoprazole in patients with duodenal ulcer disease

  1998cited by this paper
• H2‐receptor antagonists and antacids have an aggravating effect on Helicobacter pylori gastritis in duodenal ulcer patients

  1997influential reference
• Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia.

  1997cited by this paper
• Gastrin secretion from primary cultures of rabbit antral G cells: stimulation by inflammatory cytokines.

  1996cited by this paper
• Increase of Helicobacter pylori-associated corpus gastritis during acid suppressive therapy: implications for long-term safety.

  1995cited by this paper
• Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole.

  1995cited by this paper
• Gut Peptides: Biochemistry and Physiology

  1994cited by this paper
• Somatostatin analogues suppress the inflammatory reaction in vivo.

  1994cited by this paper
• Role of H1 receptors and P-selectin in histamine-induced leukocyte rolling and adhesion in postcapillary venules.

  1994cited by this paper
• Visualization of cholecystokinin receptors on a subset of human monocytes and in rat spleen.

  1991cited by this paper
• Acute effects of ranitidine, famotidine and omeprazole on plasma gastrin in the rat.

  1989influential reference
• Cholecystokinin and the immune system: receptor-mediated chemotaxis of human and rat monocytes.

  1988cited by this paper

• Characterization of gastric ulcer influenced by hot-humid environment and high-sugar and high-fat diet provides a further insight into its underlying mechanism

  2025cites this paper
• Targeting P2Y14R alleviates platelet-induced NET formation and venous thrombosis through PKA/AKAP13/RhoA axis.

  2025cites this paper
• Multi-omics integration reveals that KLF improves stomach heat syndrome through intestinal flora remodeling and PI3K-Akt pathway activation.

  2025cites this paper
• Anti-inflammatory, Antioxidant, and Gastro-Protective Actions of Cardamom Essential Oil-Loaded Nanostructured Lipid Carrier in Ethanol-Induced Gastric Ulcer

  2024cites this paper
• Gastroprotective Effect of Azilsartan Through Ameliorating Oxidative Stress, Inflammation, and Restoring Hydroxyproline, and Gastrin Levels in Ethanol-Induced Gastric Ulcer

  2022cites this paper
• Gastric Mucosal Immune Profiling and Dysregulation in Idiopathic Gastroparesis

  2021cites this paper
• Ascorbic acid and retinol palmitate modulatory effect on omeprazole-induced oxidative damage, and the cytogenetic changes in S. cerevisiae and S180 cells.

  2019cites this paper
• Gastrointestinal Toxicity Biomarkers

  2019cites this paper
• Efavirenz induces interactions between leucocytes and endothelium through the activation of Mac-1 and gp150,95.

  2014cites this paper
• Progastrin Represses the Alternative Activation of Human Macrophages and Modulates Their Influence on Colon Cancer Epithelial Cells

  2014cites this paper
• Eman Sutrisna

  2013cites this paper
• Interferon titer and the 2\',5\'-oligoadenylate-synthetase activity in rat thymus lymphocytes in conditions of Omeprazol-caused hypergastrinemia

  2013cites this paper
• Evaluation of Potential Gastrointestinal Biomarkers in a PAK4 Inhibitor-treated Preclinical Toxicity Model to Address Unmonitorable Gastrointestinal Toxicity

  2012cites this paper
• EFEITO CICATRIZANTE DO EXTRATO HIDROALCOÓLICO DE Salvia officinalis L. EM ÚLCERAS GÁSTRICAS INDUZIDAS POR ÁCIDO ACÉTICO EM RATOS

  2010cites this paper
• Antioxidant pre-treatment prevents omeprazole-induced toxicity in an in vitro model of infectious gastritis.

  2010cites this paper
• Gastrin: an acid-releasing, proliferative and immunomodulatory peptide?

  2010cites this paper
• Gastrin induces the interaction between human mononuclear leukocytes and endothelial cells through the endothelial expression of P-selectin and VCAM-1.

  2009cites this paper